Characterization of the naturally occurring Arg344His variant of the human 5-HT3A receptor

Pharmacological Reports

Volumn 61, Issue 5, 2009, Pages 785-797

  Combrink, Sandra ^a   Kostanian, Arevat ^a   Walstab, Jutta ^a   Barann, Martin ^a,b   Brüss, Michael ^a   Göthert, Manfred ^a   Bönisch, Heinz ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Aequorin luminescence Ca 2+ assay; HEK293 cells; Human 5 HT3A receptor; Patch clamp studies; Serotonin receptor; Variant Arg344His receptor; H GR65630 binding

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; 2 METHYLSEROTONIN; 3 (5 METHYL 1H IMIDAZOL 4 YL) 1 (1 METHYL 1H INDOL 3 YL) 1 PROPANONE; AEQUORIN; AZASETRON; ONDANSETRON; PHENYLBIGUANIDE; QUIPAZINE; RECOMBINANT PROTEIN; SEROTONIN 3 AGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 3A RECEPTOR; TROPISETRON; TUBOCURARINE CHLORIDE;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ASSAY; CELL DENSITY; CELL MEMBRANE POTENTIAL; CELL STRAIN HEK293; CHANNEL GATING; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; HUMAN; HUMAN CELL; LIGAND BINDING; LUMINESCENCE; NUCLEOTIDE SEQUENCE; WILD TYPE;

EID: 70549094268     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70134-3     Document Type: Article

References (37)

1. 3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects. Naunyn Schmiedebergs Arch Pharmacol, 2000, 362, 255-265.
2. Belelli D, Balcarek JM, Hope AG, Peters JA, Lambert JJ, Blackburn TP: Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit. Mol Pharmacol, 1995, 48, 1054-1062. (Pubitemid 26009704)
3. Boyd GW, Low P, Dunlop JI, Robertson LA, Vardy A, Lambert JJ, Peters JA, Connolly CN: Assembly and cell surface expression of homomeric and heteromeric 5-HT3 receptors: the role of oligomerization and chaperone proteins. Mol Cell Neurosci, 2002, 21, 38-50. (Pubitemid 35178498)
4. 3A). J Physiol, 1998, 507, 653-665.
5. 3A receptor isoforms. Naunyn Schmiedebergs Arch Pharmacol, 2000, 362, 392-401.
6. 1B receptor. Pharmacogenetics, 1999, 9, 95-102.
7. 1A receptor: impairment of signal transduction. Pharmacogenet Genomics, 2005, 15, 257-264.
8. Chen C, Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol, 1987, 7, 2745-2752.
9. 3A receptor. Abstract (No.626.6) to the annual Meeting of the Society for Neuroscience, San Diego, 2004.
10. Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF: The 5-HT subunit is a major determinant of serotonin-receptor function. Nature, 1999, 397, 359-363. (Pubitemid 29061650)
11. 3A receptors in cells of the immune system. Scand J Rheumatol, 2004, 33, Suppl 119, 9-11. (Pubitemid 39180179)
12. Fink KB, Göthert M: 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev, 2007, 59, 360-417.
13. Göthert M, Propping P, Bönisch H, Brüss M, Nöthen MM: Genetic variation in human 5-HT receptors: potential pathogenetic and pharmacological role. Ann NY Acad Sci, 1998, 861, 26-30.
14. Hoyer D, Hannon JP, Martin GR: Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav, 2002, 71, 533-554. (Pubitemid 34219205)
15. 3A receptor contributes to receptor desensitization mechanism. J Biol Chem, 2006, 281, 21781-21788.
16. 3A receptors links agonist binding to channel gating. J Biol Chem, 2003, 278, 46583-46589.
17. Hussy N, Lukas W, Jones KA: Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors. J Physiol, 1994, 481 ( Pt 2), 311-323.
18. 3 receptor trafficking in live cells: from biosynthesis to endocytosis. J Biol Chem, 2004, 279, 53346-53352.
19. 3 receptor channel. Annu Rev Physiol, 1995, 57, 447-468.
20. 3 receptors. Nature, 2003, 424, 321-324.
21. Kiel S, Bönisch H, Brüss M, Göthert M: Impairment of signal transduction in response to stimulation of the naturally occurring Pro279Leu variant of the h5-HT7(a) receptor. Pharmacogenetics, 2003, 13, 119-126. (Pubitemid 36259591)
22. Kiel S, Brüss M, Bönisch H, Göthert M: Pharmacological properties of the naturally occurring Phe-124-Cys variant of the human 5-HT receptor: changes in ligand binding, G-protein coupling and second messenger formation. Pharmacogenetics, 2000, 10, 655-666.
23. Krzywkowski K, Jensen AA, Connolly CN, Bräuner-Osborne H: Naturally occurring variations in the human 5-HT gene profoundly impact 5-HT receptor function and expression. Pharmacogenet Genomics, 2007, 17, 255-266. (Pubitemid 46668049)
24. 3A receptor. Pharmacogenetics, 2004, 14, 165-172. (Pubitemid 38373110)
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem, 1951, 193, 265-275.
26. Miyake A, Mochizuki S, Takemoto Y, Akuzawa S: Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. Mol Pharmacol, 1995, 48, 407-416.
27. 3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene, 2003, 310, 101-111. (Pubitemid 36703304)
28. Niesler B, Walstab J, Combrink S, Möller D, Kapeller J, Rietdorf J, Bönisch H et al.: Characterization of the novel human serotonin receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E. Mol Pharmacol, 2007, 72, 8-17.
29. Niesler B, Weiss B, Fischer C, Nöthen MM, Propping P, Bondy B, Rietschel M et al.: Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients. Pharmacogenetics, 2001, 11, 21-27. (Pubitemid 32108658)
30. 2A receptor and response to clozapine. Lancet, 1995, 346, 908-909.
31. 2A receptor influences amplitude and timing of intracellular calcium mobilization. J Neurochem, 1997, 68, 2186-2193. (Pubitemid 27176157)
32. Rotondo A, Nielsen DA, Nakhai B, Hulihan-Giblin B, Bolos A, Goldman D: Agonist-promoted down-regulation and functional desensitization in two naturally occurring variants of the human serotonin1A receptor. Neuropsychopharmacology, 1997, 17, 18-26. (Pubitemid 27259709)
33. 3 receptor transmembrane topology. J Mol Neurosci, 2002, 18, 169-178.
34. Sun H, Hu XQ, Moradel EM, Weight FF, Zhang L: Modulation of 5-HT receptor-mediated response and trafficking by activation of protein kinase C. J Biol Chem, 2003, 278, 34150-34157.
35. 3A receptor function and trafficking. Abstract to the annual Meeting of the Society for Neuroscience, Washington, 2008.
36. Thompson AJ, Sullivan NL, Lummis SC: Characterization of 5-HT receptor mutations identified in schizophrenic patients. J Mol Neurosci, 2006, 30, 273-281.
37. Walstab J, Combrink S, Brüss M, Göthert M, Niesler B, Bönisch H: Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization. Anal Biochem, 2007, 368, 185-192. (Pubitemid 47198568)